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ABSTRACT
Macrophage plasticity is critical for controlling inflammation including those 
produced by helminth infections, where alternatively activated macrophages (AAM) 
are accumulated in tissues. AAM expressing the co-inhibitory molecule programmed 
death ligand 2 (PD-L2), which is capable of binding programmed death 1 (PD-
1) expressed on activated T cells, have been demonstrated in different parasitic 
infections. However, the role of PD-L2 during F. hepatica infection has not yet been 
explored. We observed that F. hepatica infection or a F. hepatica total extract (TE) 
injection increased the expression of PD-L2 on peritoneal macrophages. In addition, 
the absence of PD-L2 expression correlated with an increase in susceptibility to F. 
hepatica infection, as evidenced by the shorter survival and increased liver damage 
observed in PD-L2 deficient (KO) mice. We assessed the contribution of the PD-L2 
pathway to Th2 polarization during this infection, and found that the absence of PD-L2 
caused a diminished Th2 type cytokine production by TE stimulated splenocytes from 
PD-L2 KO infected compared with WT mice. Besides, splenocytes and intrahepatic 
leukocytes from infected PD-L2 KO mice showed higher levels of IFN-γ than those 
from WT mice. Arginase expression and activity and IL-10 production were reduced 
in macrophages from PD-L2 KO mice compared to those from WT mice, revealing a 
strong correlation between PD-L2 expression and AAM polarization. Taken together, 
our data indicate that PD-L2 expression in macrophages is critical for AAM induction 
and the maintenance of an optimal balance between the Th1- and Th2-type immune 
responses to assure host survival during F. hepatica infection.
INTRODUCTION
The helminth parasite F. hepatica is the causative 
agent of liver fluke disease (fasciolosis) in cattle and sheep, 
with the liver damage caused by these parasites reducing 
animal performance, fertility, wool and milk production, 
and resulting in huge economic losses worldwide [1]. 
Moreover, fasciolosis is becoming an emerging disease in 
humans, with a high prevalence in some regions of the 
planet such as Bolivian Altiplano [2].
The parasite’s life cycle involves a complex 
interplay between parasite and host. Following ingestion 
by grazing animals, the parasites emerge from their cysts 
in the intestine, traverse the intestinal wall, in just a few 
hours, before migrating through the liver capsule and 
into the parenchyma. There, their feeding and migratory 
activities cause tissue perforation and hemorrhage, leading 
to extensive tissue damage. After about 7–8 weeks, the 
parasites migrate into the bile ducts, mature and produce 
eggs which are released onto the pasture with the faeces 
[3]. It is assumed that during the evolution both, the host’s 
immune system and the parasites, exert reciprocal selective 
pressures on each other which leads to rapid reciprocal 
adaptation to survival. Thus, F. hepatica infection in mice 
induces a strong Th2 immune response with high IL-4, 
IL-5 and IL-10 but little IFN-γ production by parasite 
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stimulated splenocytes [4-6]. In the same way, although 
in infected cattle both Th1- and Th2-type immune 
responses are present at the early stages of infection, a 
high prevalence of the Th2 response is observed when 
the infection is established [7]. In addition, F. hepatica 
infection as well as the excretory-secretory products 
(ES) released by the parasite are immunomodulatory, 
promoting Treg induction and AAM that suppress the 
Th1-type immune and promote Th2 development through 
IL-10 production [8-11]. Collectively, this prevents the 
development of a protective Th1-type immune response 
against the parasite, thereby allowing the development of 
a chronic infection.
The immunomodulatory capacity of F. hepatica 
products has been shown in murine models of co-infection 
with other pathogens such as Bordetella pertussis, in 
which the cellular immune response against Bordetella 
is abrogated resulting in a delayed clearance of the 
bacteria and poor B. pertussis-specific IFN-γ production 
[4]. Furthermore, injection of purified cathepsin L 
proteinase from F. hepatica is capable of suppressing B. 
pertussis-specific IFN-γ production by a IL-4-dependent 
mechanism [12]. In line with this, a correlation between 
increased levels of IL-4 with decreased IFN-γ production 
was observed in calves co-infected with F. hepatica and 
Mycobacterium bovis BCG [13], thus highlighting the 
suppressive effect of F. hepatica on the IFN-γ production 
induced by a concurrent pathogen.
T cell activation and tolerance are controlled by 
costimulatory molecules with the PD-1 pathway involving 
the negative signaling of the accessory molecules PD-L1 
and PD-L2, which bind PD-1 expressed in activated T 
cells inhibiting their proliferation [14, 15]. In particular, 
PD-L2 is a negative regulator of T cell activation, but 
is also essential for the regulation of T cell tolerance 
[16]. During helminth infections, the suppression of 
T cell responses by PD-1 has been mostly attributed to 
macrophages expressing PD-L1 and /or PD-L2, and 
the PD-1 pathway has been shown to be an important 
mechanism of suppression by AAM [17, 18]. Related to 
this, it has recently been demonstrated that F. hepatica 
ES induce CD4+ T cell anergy via selective up-regulation 
of PD-L2 expression in macrophages [19]. Furthermore, 
blocking of PD-L2 in co-cultures of anti-CD3-stimulated 
CD4+ T cells with ES-treated macrophages increases 
IFN-γ and decreases IL-10 production [19]. From these 
results, it appears that ES from F. hepatica might exert a 
control of the Th1-type response through PD-L2.
Based on the above findings, and given that 
protective immune response against F. hepatica is 
mostly related to the induction of Th1 responses, we 
investigated the role of PD-L2 expression during F. 
hepatica infection and its influence on the control of the 
protective immune response and the immunopathology. 
Here, we demonstrated that PD-L2 expression was up-
regulated in macrophages during F. hepatica infection, 
and that its expression was critical for inducing AAM. In 
addition, the absence of PD-L2 expression was correlated 
with an increase susceptibility to F. hepatica infection, as 
evidenced by a reduction in survival rate and increased 
liver damage in PD-L2 KO mice. Concomitantly, a 
reduction in the production of the Th2-type cytokines 
IL-4 and IL-10 was observed in splenocytes from infected 
PD-L2 KO mice, and an increased production of IFN-γ 
was found in splenocytes and intrahepatic leucocytes from 
these animals. Based on these observations, we postulate 
that increased PD-L2 expression in macrophages at early 
time post-infection may be involved in the control of 
the incipient Th1 response to protect the host from an 
excessive immune response that could cause liver damage.
RESULTS
F. hepatica infection increased PD-L2 expression 
in peritoneal macrophages
During helminth infections, there is a predominant 
Th2 response characterized by a high production of IL-4, 
IL-5, IL-9, IL-10 and IL-13 cytokines [20]. In addition, it 
has been shown that the costimulatory molecule PD-L2 
expressed in macrophages, among other cells, is strongly 
induced by IL-4 and correlates with other established 
markers for AAM, thereby serving as a useful molecule 
to identify AAM [21]. F. hepatica, in common with other 
helminth parasites, induces AAM in murine and ruminants 
through several products such as ES, protein thioredoxin 
peroxidase and fatty acid binding protein [8-10]. Taking 
the above into account, we first studied whether F. hepatica 
infection or TE injection were able to modify PD-L2 
expression in peritoneal macrophages, since the parasite 
migrates through the peritoneal cavity before reaching the 
liver. To carry this out, we evaluated at different times post 
infection (p.i) the percentage of F4/80+ PD-L2+ cells in the 
peritoneal lavage of F. hepatica infected and TE injected 
mice. We observed that in both infected (Figure 1A) and 
TE injected (Figure 1B) groups of mice, the percentage 
of macrophages that expressed PD-L2 was significantly 
increased compared with uninfected or PBS injected mice, 
respectively.
PD-L2 expression is involved in F. hepatica 
infection outcome
To determine the relevance of PD-L2 expression 
during F. hepatica infection, susceptible BALB/c WT 
and PD-L2 KO mice were infected and the survival rates 
evaluated. After infection, almost all control mice (WT) 
died between days 26 to 47, while all PD-L2 KO mice 
died in the period 22 to 28 days p.i (Figure 2A). The level 
of damage was evaluated in the liver (target organ of 
infection) by analyzing the histopathology changes, with 
PD-L2 KO mice revealing a wide range of hepatic lesions 
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and inflammatory signs (Figure 2B and Table 1). Livers 
from both WT and PD-L2 KO mice showed granulocytic 
inflammatory infiltrate, necrosis, hemorrhage and fibrosis, 
with all these characteristics being more severe in the 
livers from PD-L2 KO mice (Figure 2B and Table 1). 
In addition, the total liver leukocyte infiltration was 
significantly increased in PD-L2 KO compared to WT 
infected mice (Figure 2C).
In order to determine whether liver infiltrating 
leukocytes can produce any mediators able to favor 
hepatic lesion, we measured NO production by Ly6G+ 
cells and found that the percentage of NO-producing cells 
was higher in PD-L2 KO compared to WT infected mice 
(8,01 vs 4,29 respectively) (Figure 2D).
Taken together, the above results indicate that 
PD-L2 expression is important for prolonging the survival 
of F. hepatica infected mice by restricting inflammatory 
liver damage.
PD-L2 expression is involved in Th1-Th2 balance 
and macrophage activation
Considering that PD-L2 is involved in both the 
regulation of T cell activation and tolerance [16], together 
with the fact that in our study F. hepatica infected PD-
L2 KO mice showed a strong inflammatory liver damage, 
we hypothesized that PD-L2 expression is important for 
maintaining a survivable Th1 and Th2 cell balance during 
Figure 1: Effect of F. hepatica infection or total extract antigen injection on PD-L2 expression by peritoneal macrophages. 
A. BALB/c mice were infected with 8 F. hepatica metacercariae, and PC were isolated at days 1, 3 and 7 p.i. Uninfected animals were 
analyzed in parallel as controls. PC were processed by flow cytometry and analyzed for F4/80+PD-L2+ cells. Representative dot plots of 
each group of mice are shown, with bars displaying the percentage of PD-L2+ cells gated on F4/80+ cells, ** p< 0.005. B. BALB/c WT 
mice were injected with 80 µg of TE or PBS as control and the PC were obtained 24 h later. F4/80+ PD-L2+ cells were analyzed by flow 
cytometry. A representative dot plot for each group of mice is shown. Bars display percentage of F4/80+ PD-L2+ cells, **p=0.0038. Data 
are representative of two independent experiments and expressed as mean ± SD.
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this infection. Thus, we evaluated cytokine production by 
splenocytes from WT and PD-L2 KO infected mice after 
being re-stimulated with F. hepatica TE for 72 h. Although 
at 7 days p.i. the Th2-type response was undetectable in 
both groups of mice (data not shown), we found low but 
significant levels of IFN-γ secreted by TE stimulated 
splenocytes from PD-L2 KO but not WT mice (Figure 3A). 
Subsequently, at day 21 p.i, TE stimulated splenocytes 
from PD-L2 KO mice showed a reduced ability to secrete 
IL-10 and IL-4 cytokines, while displaying an increased 
Figure 2: Increased susceptibility to F. hepatica infection in PD-L2 KO mice. WT and PD-L2 KO mice were orally infected 
with 8 F. hepatica metacercariae. A. Survival was followed for 50 days, *p<0.02, Gehan–Breslow Wilcoxon test, n=12 per group. B. 
Representative hematoxylin and eosin images of livers from each group are shown (400x). Arrow heads in fibrosis areas, inflammatory 
foci (IF) and the presence of worms (P) are indicated. Inset shows the extensive inflammatory infiltrate. C. Intrahepatic leukocytes were 
isolated by percoll gradient and quantified in a Neubauer chamber. Each dot represents the total liver leukocyte number in individual livers 
of each group p=0.0065. D. Intrahepatic leukocytes were stained with anti-Ly6G before being incubated with 20µM of DAF-FMDA probe 
for intracellular NO detection. Bars show the percentage of Ly6G+NO+ cells. Representative dot plots of each group of control or infected 
WT and PD-L2 mice are shown,**p= 0.021; * p=0.0149; # p=0.0354. The data are representative of two experiments with similar results, 
and are expressed as mean ± SD.
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capacity to produce IFN-γ compared to splenocytes from 
WT mice (Figure 3B). Accordingly, the percentage of 
IFN-γ-producing-CD4+ and CD8+ splenocytes (Figure 
3C), as well as IFN-γ-producing-CD4+ intrahepatic T cells 
were significantly increased in PD-L2 KO compared with 
WT mice (Figure 3D).
It has been previously demonstrated that F. hepatica 
infection as well as ES released by the parasite induce 
AAM, which contributes to suppressing the Th1-type 
immune response and promoting Th2 development [9, 
19]. In addition, it has been shown that PD-L2 expression 
in F. hepatica ES treated-macrophages is important in 
suppressing and inducing the secretion of IFN-γ and IL-
10 by T cells, respectively [19]. In order to investigate 
whether PD-L2 expression participates in the alternative 
activation of macrophages, TE was injected into WT 
and PD-L2 KO mice, and arginase I expression and 
activity were evaluated in peritoneal cells (PC) after 24 
h. Although TE induced arginase I expression in PC from 
both groups of mice, PC from WT mice showed more than 
a two-fold increase in arginase I expression, in comparison 
to a minor increase observed in PC from PD-L2 mice 
(Figure 4A). In agreement, TE induced arginase I activity 
on PC from WT mice (Figure 4B).
Next, we tried to determine whether PD-L2 
expression played a role in inducing the alternative 
activation of macrophages during F. hepatica infection, 
by assessing, arginase I expression and activity and the 
levels of arginase I/IL-10 expressing cells in PC from WT 
and PD-L2 KO infected mice. Remarkably, after 3 and 7 
days p.i, PC from PD-L2 KO mice showed a significant 
reduction in arginase I expression and activity (Figure 4C 
and 4D) and in the frequency of arginase I+ IL-10+ gated 
on F4/80+ cells (Figure 4E), compared to WT mice.
In addition, as previously demonstrated during F. 
hepatica infection [8] and other helminth infections [18], 
the expression of iNOS, a marker of classical activation of 
macrophages, was not detected in PC from WT or PD-L2 
KO TE-injected mice (Figure 4A).
Taken together, these results indicate that PD-L2 
expression in macrophages is critical for the induction of 
AAM and for maintaining an optimal balance between 
the Th1- and Th2-type immune responses that assure host 
survival during F. hepatica infection.
DISCUSSION
It is known that F. hepatica infection leads to a 
polarization of the immune response towards a Th2 
profile in various animals, including sheep, cattle and 
mice [1]. In addition, the ability of the parasite to limit 
a pro-inflammatory Th1-type profile by promoting anti-
inflammatory responses that depend on the Th2 response 
and Treg induction has also been demonstrated [4, 11, 
12]. Nevertheless, it is still not fully understood how 
parasite antigens modulate antigen presenting cells (APC) 
activation to promote a Th2 response and control the Th1 
immune response.
In this study, we showed that F. hepatica infection or 
intraperitoneal TE injection increased PD-L2 expression 
in macrophages from susceptible BALB/c mice. 
Concomitantly, we demonstrated that in the absence of 
PD-L2, F. hepatica infection induced fatal inflammatory 
liver damage, with high IFN-γ but reduced IL-10 and 
IL-4 production by splenocytes from infected mice. 
Based on these findings, we postulate that increased PD-
L2 expression on macrophages at early p.i times (from 
day 1 to day 7) could promote control of the incipient 
Th1 response. Supporting this idea, Guasconi et al. [19] 
demonstrated using in vitro experimental settings that the 
blocking of PD-L2 in co-cultures of F. hepatica-ES-treated 
macrophages with anti-CD3-stimulated CD4+ T cells 
increases IFN-γ and decreases IL-10 production, without 
modifying IL-13 production. Similar results were observed 
by blocking PD-L2 in the co-cultures of bone marrow-
derived dendritic cells (DC) stimulated with Schistosoma 
mansoni soluble egg antigens (ESA) and CD4+ T cells, 
where a significant rise in IFN-γ was observed [22].
The role of PD-L2 has been previously demonstrated 
in the control of the expansion of Th2 response [23]. Thus, 
we have previously demonstrated contrasting results 
for the PD-1-PD-L2 signaling pathway in peritoneal 
Table 1: Histopathological changes in livers from WT and PD-L2 KO mice infected with F. hepatica
WT PD-L2 KO
Necrosisa +++ ++++
Wormsa ++ ++
Inflammatory infiltratea +++ ++++
(main cell type)b (PMN/Mo/Eo/Ly) (PMN/Mo/Eo/Ly)
Hemorragic focia + +++
Fibrosisa + +++
aScale: + mild, ++ moderate; +++ severe; ++++ very severe.
bPMN: Polymorfonuclear cells; Mo: monocytes; Eo: eosinophils; Ly: lymphocytes.
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macrophages during T. cruzi infection, with PD-L1 but not 
PD-L2 expression involved in T cell suppression, while 
PD-L2 expression was involved in the control of arginase 
I and up-regulation of iNOS activity [24]. In addition, 
during Nippostrongylus brasiliensis infection, AAM 
expressing PD-L2 participate in the inhibition of Th2-
type response, with in vivo blockade of PD-L2 inducing 
an enhancement of the Th2-type immune response in the 
lung [21]. Furthermore, it has also been demonstrated 
that during chronic filarial infection with the nematode 
Litomosoides sigmodontis, the diminished ability of 
Th2 cells to proliferate and produce IL-4, IL-5 and 
IL-2 cytokines is reversed by PD-L2 blockage, thereby 
confirming the role of PD-L2 in the control of the Th2 
Figure 3: Th1 and Th2 cytokine levels in WT and PD-L2 KO infected mice. Spleen mononuclear cells were obtained from WT 
and PD-L2 KO mice orally infected with 8 F. hepatica metacercariae. Then, the cells were stimulated with 80 μg/ml of TE or left unstimulated, 
and the cytokines measured in culture supernatants by ELISA. A. IFN-γ production by splenocytes at days 3 and 7 p.i. Dots represent mean 
cytokine levels of individual animals, lines represent the mean value *p<0.05 B. IL-10, IL-4 and IFN-γ production from splenocytes at day 
21 p.i. Bars show fold increase of TE stimulated vs unstimulated cells. Data are expressed as mean ± SD *p<0.05;**p<0.005. C. CD4+ 
and CD8+ splenocytes producing IFN-γ are shown, each dot represents an individual animal *p<0.05. D. CD4+ intrahepatic lymphocytes 
producing IFN-γ are shown, with each dot representing an individual mouse * p<0.05. One representative experiment is depicted out of two.
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response [23]. Consequently, it is not clear why the PD-1-
PD-L2 signaling pathway can alternatively control Th1 or 
Th2 responses in different experimental settings. Related 
to this, the role of AAM (which have a high expression 
of PD-L2) in regulating the immune response during 
helminth infection, is still not completely understood.
Although during helminth infections there is a 
predominance of the Th2 response, in some instances, 
such as the infection with the intestinal nematode Trichuris 
muris or the trematode Schistosoma mansoni, there is 
a strong underlying Th1 inflammatory response which 
may became pathogenic if the dominant Th2 response 
is inhibited. Thus, it is possible that depending on the 
microenvironment where the helminth parasite develops 
its life cycle, AAM might exert a control on excessive 
inflammatory Th1 or Th2 responses, otherwise this could 
result in being deleterious to the parasite and/or to the host 
[25].
Is not clear yet how PD-L2 signaling can contribute 
to controlling the Th1 response during early time of 
F. hepatica infection. We hypothesize that this could 
be due to a direct effect on Th1 cell proliferation or 
indirectly through the promotion of AAM, favoring the 
Th2 response, which is mainly involved in the control 
of the Th1 response. In this regard, our results together 
with previous reports [19] suggest that Dectin-1 signaling 
by F. hepatica products induces PD-L2 expression in 
peritoneal macrophages, with its expression being critical 
for inducing up-regulation of arginase I expression and 
activity on PC from both F. hepatica infected and TE 
Figure 4: Reduced alternative activation of macrophages in total extract antigen (TE) injected or infected PD-L2 KO. 
A. BALB/c WT and PD-L2 KO mice were injected with 80 µg of TE or PBS as control, and 24 h later arginase I and iNOS expression 
mice were analyzed in PC by Western blot. Mouse liver lysate was used as a positive control for arginase I expression and LPS-stimulated 
J774 cells were used as a positive control for iNOS expression. ATP Citrate expression was used as control loading. Right panel shows the 
densitometric analysis using GelPro software, n =2 experiments **p=0.0011; *p< 0.05. B. Arginase activity was evaluated by measuring 
urea levels in lysated PC, ***p=0.0003. C. WT and PD-L2 KO mice were infected with 8 F. hepatica metacercariae, and the PC were 
isolated at days 3 and 7 pi. Arginase I expression was measured by Western blot. Mouse liver lysate was used as a positive control for 
Arginase I expression, and Actin expression was analyzed as control loading. Right panel shows the densitometric analysis using GelPro 
software, n =2 experiments **p=0.0046; *p<0.05. D. Arginase activity was evaluated through urea production *p<0.05. E. PC were stained 
with anti-F4/80 antibody. Then, PC were fixed and permeabilized to evaluate arginase I and IL-10 expression by using APC labeled anti-
arginase I antibody and a PE-Cy7 labeled anti-IL-10 antibody. Left panel: representative dot plots for each group of mice at days 3 and 7 
p.i. are shown. Right panel: Bars display the percentage of IL-10+ arginase I+ cells on F4/80+ gated populations, *p <0.05. All experiments 
were repeated twice with similar results being obtained and are expressed as mean ± SD.
Oncotarget77728www.impactjournals.com/oncotarget
injected mice, thus indicating a role for PD-L2 in the 
induction of AAM. Therefore, AMM promotes a Th2-type 
immune response that can control the Th1-type response 
by several mechanisms, including the secretion of IL-10, 
which inhibit the production of IL-12 by DC [26], or 
galectin-1, an immunomodulatory lectin that selectively 
induces Th1 apoptosis and promotes the Th2 function 
[27]. The control of Th1 cells during F. hepatica infection 
through the PD-L2 expression may be also attributable to 
Treg induction and/or expansion. However, the similar 
levels of CD4+ CD25+ Foxp3+ Treg cells in liver and 
spleen from WT and PD-L2 KO infected mice (data not 
shown), indicated the lack of involvement of Treg cells in 
this phenomenon.
During acute phase of F. hepatica infection, larva 
migration, hemorrhages, infiltration with eosinophils, 
lymphocytes, and macrophages, fibrosis, and necrotic 
areas have been reported [3]. Here, we have reported 
exacerbated liver damage in PD-L2 KO mice as denoted 
by hepatocyte enlargement, cytoplasmic vacuolization, 
and regions of cellular infiltration and foci of necrosis, 
hemorrhage and fibrosis. All these features might be 
associated with the unregulated Th1-type specific immune 
response developed by PD-L2 KO mice after F. hepatica 
infection. Consistent with these data, it has been reported 
that during HBV infection, the virus-specific Th1-type 
response is critical in the pathogenesis of fulminant 
hepatitis [28]. It has been demonstrated that during T. cruzi 
infection pro-inflammatory Th1-type cytokines as TNF 
can exert deleterious effects on tissues [29], however we 
found similar levels of TNF in sera from PD-L2 KO and 
WT mice (data not shown).
Here we showed that despite the increased 
recruitment of granulocytes and higher percentage of 
IFN-γ-producing CD4+ T cells in the livers of PD-L2 KO 
mice, the number of worms was similar to that observed 
in WT mice. This might be explained by the excessive 
production of NO by intrahepatic leukocytes, which in 
some infections is clearly associated with a more severe 
or even fatal disease outcome with possible underlying 
mechanisms including NO-mediated cytotoxicity and 
tissue damage, inhibition of T cell proliferation and/or 
induction of T cell apoptosis [30-32]. In agreement, during 
a thioacetamide-induced rat model of acute hepatic failure, 
the inhibition of iNOS activity by using the L-NAME 
and aminoguanidine significantly reduces the severity of 
damage and decreases mortality [33]. Moreover, increased 
NO, O
2
− and ONOO production has been shown in IL-4 
KO mice infected with Schistosoma mansoni, which 
correlated with greater liver damage and an inability to 
control the parasite burden in the liver [34].
Interestingly, according to our data, besides being 
relevant to the T cell polarization, during a helminth 
infection PD-L2 signaling seems to have a role in 
alternative macrophage polarization, suggesting a reverse 
or back-signaling through this molecule in macrophages. 
PD-L2 expression would allow macrophages to reach a 
phenotype that includes the expression and activity of 
arginase and the production of IL-10, two markers of 
AAM. Thus, in the absence of PD-L2, macrophages 
obtained at early times post F. hepatica infection, show 
an inability to be completely polarized to AAM compared 
with those from WT mice. These results are in contrast 
with those published by Kuipers et al, who showed that 
blocking of PD-L1 and PD-L2 with soluble PD-1-Ig 
fusion protein leads to a reduced DC maturation with 
an increased IL-10 production [35]. The basis of these 
differences are not clear yet, but we speculate that the 
use of soluble PD-1-Ig fusion protein can block both PD-
L1 and PD-L2 molecules, while in our study we used 
macrophages from mice deficient only in PD-L2. Studies 
tending to identify differentially regulated genes in the 
absence of PD-L2 in infected macrophages, would allow 
to dissect the reverse signals that are activated through 
PD-L2 during a helminth infection.
Taken together, our data demonstrates that during 
F. hepatica infection, the PD-L2 signaling pathway 
is involved in alternative macrophage polarization 
as well as in the control of the underlying Th1-type 
immune response, and concomitantly plays a key role in 
determining the susceptibility to this heminth infection.
MATERIALS AND METHODS
Mice, antigen preparation and F. hepatica 
infection
BALB/c mice were obtained from the Comisión 
Nacional de Energía Atómica (CNEA; Buenos Aires, 
Argentina), and PD-L2 KO mice were generously donated 
by Dr Frank Housseau and Dr Drew Pardoll (Johns 
Hopkins University, Baltimore, MD). All mice were 
inbred and housed according to institutional guidelines, 
and used when between 2 and 3 months of age. The 
animal experiments were examined by The Institutional 
Experimentation Animal Committee (authorization no. 
15-01-44195), which approved the animal handling and 
experimental procedures.
The total extract (TE) of F. hepatica was obtained 
from mature flukes of infected bovine livers, as previously 
described [36]. Mice were injected intraperitoneally with 
80 µg of TE or PBS as control, and F. hepatica infection 
was carried out by giving 8 metacercariae orally (Baldwin 
Aquatics) per animal. At different time points post 
infection (p.i), mice were necropsied, and their livers, 
spleens, and PC were removed.
PC harvesting
Resident PC from injected, infected or control 
animals were obtained by washing the peritoneal cavity 
with completed RPMI-1640 supplemented with 10% 
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fetal bovine serum (FBS, PAA laboratories), L-glutamine 
(2 mM) and gentamicin (40 g/ml) and the cells were 
cultured in completed RPMI-1640. The PC were removed 
1, 3 or 7 days p.i or 24 h post-injection from peritoneal 
cavity of WT or PD-L2 KO mice. Additionally, PC were 
collected from uninfected or PBS-injected animals and 
used as a control group. Cells were used to assay the 
surface expression of PD-L2, arginase expression and 
activity and IL-10 expression.
Isolation of mouse intrahepatic leukocytes
Intrahepatic leukocytes (IHLs) were isolated from 
all mouse groups as previously described [37]. Briefly, 
liver in RMPI medium containing gentamicin (both from 
Gibco) plus 1% of FBS (PAA laboratories) was passed 
through 100-mm nylon meshes, red blood cells were 
removed using lysis buffer (Sigma) and finally IHLs were 
obtained after 20 min centrifugation (600 × g) in 35% and 
70% bilayer Percoll (Sigma) gradients. The viable cell 
number was obtained by Trypan blue exclusion. Then, IHL 
were incubated with a probe and stained with anti-Ly6G, 
and cells DAF-FMDA probe for 15 min to determine 
Nitric oxide (NO) production by flow cytometry.
Tissue preparation and staining
Livers were isolated from infected WT and PD-
L2 KO mice fixed in 4% paraformaldehyde-PBS pH 
7.4. Paraffin sections were cut and slides were stained 
with hematoxylin and eosin (H&E) and the histological 
features were scored. At least 5 livers were included in 
each experimental group. Images were obtained using a 
Nikon Eclipse TE 2000U equipped with a digital video 
camera.
Fluorescence-Activated Cell-Scanning (FACS) 
Analysis
To examine PD-L2 expression, the PC were 
removed 1, 3 or 7 days p.i or 24 h post-injection from the 
peritoneal cavity of WT or PD-L2 KO mice. Additionally, 
PC were collected from uninfected animals or PBS 
injected animals and used as control groups. Cells were 
washed with saline solution 2% FBS and incubated with 
anti-mouse CD32/CD16 antibody for 20 minutes at 4°C 
to block Fc receptors. Then, cells were incubated with 
FITC labeled mAb against mouse F4/80 (BD Pharmingen) 
and with PE labeled mAb against mouse PD-L2 (BD 
Pharmingen) for 20 min at 4°C.
In addition intracellular expression of IFN-γ in 
spleen cells or IHLs was measured after treatment with 
1 μg/ml brefeldin A (BD Pharmingen) and Phorbol 
myristate acetate (PMA) (Sigma) for 4 h at 37°C and 5% 
CO
2
. Spleen cells and IHLs were first stained with PerCP-
conjugated anti-CD3, PE-conjugated anti-CD8 and APC-
Cy7-conjugated anti-CD4 antibodies (BD Pharmingen). 
Once stained, the cells were permeabilized and fixed, and 
APC-conjugated anti-IFN-γ (BD Pharmingen) was added.
For the assessment of intracellular arginase I and 
IL10 expression, monensin (BD Pharmingen) was added 
to PC cultures at a final concentration of 2 μM during 4 
h. Then, cells were stained with PE-F4/80 antibody, and 
then fixed and permeabilized with Citofix/Citoperm (BD 
Biosciences) followed by reacting with APC-labeled 
anti-arginase I antibody (R&D) and PE-Cy7-labeled anti-
IL-10 antibody (Biolegend) for 45 min. Finally, cells were 
washed twice with saline solution 2% FBS, and stored at 
4°C in the dark until being analyzed using a FACS flow 
cytometer (FACS Canto II, BD Biosciences).
Isotype controls were run with each set of samples 
and were used to define negative and positive cell 
populations. The results were processed using Flow Jo 
software.
Arginase activity determination
PC (1x105) were obtained from TE and PBS injected 
animals or from control and infected animals and the 
arginase activity was measured in cell lysates as described 
elsewhere [38, 39]. Briefly, cells were lysed with 50 µl 
of 0.1% Triton X-100 containing protease inhibitors and 
the mixture was stirred for 30 min and then 50 µl of 10 
mM MnCl
2
 with 50 mM Tris-HCl were added to activate 
the enzyme for 10 min at 56 oC. Arginine hydrolysis was 
initiated by the addition of 25 µl of 0.5 M L-arginine, 
pH 9.7 at 37 oC for 45 min. The reaction was stopped 
using a mixture of acids, and the urea concentration 
was measured at 540 nm after the addition of 25 µl of 
α-isonitrosopropiophenone (dissolved in 100% ethanol), 
which was followed by heating at 95 oC for 45 min. These 
results are expressed as µg of urea per µg of protein.
Cytokine determination
Cytokines were measured in culture supernatants 
using capture enzyme-linked immunosorbent assay 
(ELISA). IFN-γ (eBioscience), IL-10 and IL-4 (Biolegend) 
were used as paired monoclonal antibodies in combination 
with recombinant cytokine standards. Assays were 
performed according to the manufacturer’s guidelines.
Immunoblot analysis
To examine arginase I or iNOS expression, PC were 
removed from BALB/c or PD-L2 KO, TE or PBS injected 
mice. Additionally PC were isolated from BALB/c or PD-
L2 KO infected mice. Cells were washed and lysed for 30 
min at 4oC in RIPA buffer [1% Triton X-100 (v/v), 0.5% 
sodium deoxicolate (p/v), 0.1% sodium dodecyl sulfate 
(SDS)] containing protease inhibitor cocktail (Roche) 
and cell debris was spun down at 13,000 g for 15 min. 
Precipitates were removed, and aliquots of the cell lysates 
were diluted in SDS sample buffer, boiled at 100°C for 
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3 min, spun down, and applied to precast 10% acrylamide 
Tris-glycine gels at 40 µg protein/lane and run at 150 V for 
1 h. Samples were transferred to nitrocellulose membrane 
(BioRad) at 100 V for 1 h and membranes were probed 
using rabbit anti-mouse arginase I polyclonal antibody or 
rabbit anti-mouse iNOS polyclonal antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA) followed by peroxidase 
conjugated anti-rabbit antibody (Sigma Chemical Co.) and 
visualized using enhanced chemiluminescence (Pierce) 
for detection. Moreover rabbit anti-mouse ATP citrate or 
monoclonal anti-mouse β-actin antibodies (Cell Signalling 
Technology) were used for control loading.
Statistical analysis
Statistical analyses were performed using the 
student’s t-test and survival data were analyzed by the 
Gehan–Breslow Wilcoxon test. For both tests, p < 0.05 
values were considered to be statistically significant.
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